Neogen Morita New Materials approves ₹76.8 crore preferential issue to Morita Investment
As filed · Neogen Chemicals Limited has informed regarding Disclosure pertaining to approval by the Board of Neogen Morita New Materials Limited (NML) for issuance of equity shares of NML on Preferential Issue b
What happened
FactNeogen Morita New Materials Limited, a wholly owned subsidiary of Neogen Ionics and step-down subsidiary of Neogen Chemicals, approved the issue of 7,20,000 equity shares to Morita Investment Limited at ₹1,066.66 per share, aggregating ₹76,80,00,000. The issue was approved by NML shareholders but remains subject to Neogen Chemicals member approval and other required statutory and regulatory approvals.
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
ContradictedPakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
Dahej Phase 1 project cost stands at INR 428 crore with target completion by February 2027, while Pakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
Change
FactImplication
CapitSignal interpretationCapex
WithdrawnMorita’s equity contribution of $20 million toward the Joint Venture is scheduled for infusion by Q1 FY27
Our battery materials project remains firmly on track with projected timelines.
Change
FactImplication
CapitSignal interpretationCapex
RevisedDahej Phase 1 project cost stands at INR 428 crore with target completion by February 2027, while Pakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
Total estimated project cost for Neogen Ionics’ Dahej Phase 1 and Pakhajan Phase 2 Battery Materials projects stands at INR 1,795 crore (INR 218 crore incurred in Q1 FY27; cumulative INR 1,298 crore to date)
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
- 1,000 MT to be commissioned by H2 FY27 (management committed by H2 FY27)
- Looking ahead, as the replacement Dahej plant begins regular commercial operations and Neogen Ionics (NIL) cap (management committed by H2 FY27)
Evidence
- Neogen Chemicals Limited has informed regarding Disclosure pertaining to approval by the Board of Neogen Morita New Materials Limited (NML) for issuance of equity shares of NML on Preferential Issue basis.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q4 FY26
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- The transaction would bring Morita Investment Limited into NML with a 9.09% stake and provide ₹76,80,00,000 of proposed equity funding at the step-down subsidiary level. Completion remains conditional on further approvals, and the filing does not specify the use of proceeds.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%